IS POST-MARKETING DRUG SURVEILLANCE POSSIBLE IN THE FAMILY-PRACTICE SETTING - A COLLABORATIVE STUDY

被引：0
|
作者：
FACKLAM, DP
BAKER, MI
GARDNER, JS
HERBERT, C
GRAVAGUBINS, I
机构：
来源：
CANADIAN FAMILY PHYSICIAN | 1988年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：819 / 822
页数：4
相关论文
共 50 条
  • [41] POST-MARKETING SURVEILLANCE OF THE TRANSIDERM-NITRO PATCH IN GENERAL-PRACTICE
    BRIDGMAN, KM
    CARR, M
    TATTERSALL, AB
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1984, 12 (01) : 40 - 45
  • [42] Post-marketing surveillance of escitalopram in depressed outpatients
    Möller, HJ
    Lotze, K
    Lange, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S428 - S428
  • [43] Challenges and perspectives in surveillance of post-marketing/use
    Fontenele Martins, Mary Anne
    Coelho Penna Teixeira, Ana Paula
    VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2019, 7 (04): : 3 - 9
  • [44] COLLABORATIVE RESEARCH MODEL IN FAMILY-PRACTICE
    HESBACHER, P
    RICKELS, K
    ZAMOSTIEN, B
    PERLOFF, M
    WHEELERJENKINS, B
    JOURNAL OF FAMILY PRACTICE, 1977, 4 (05): : 923 - 927
  • [45] A Clustering Ensemble Method for Drug Safety Signal Detection in Post-Marketing Surveillance
    Chakraborty, Shubhadeep
    Tiwari, Ram
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025, 59 (01) : 89 - 101
  • [46] INFORMATION-SYSTEM FOR POST-MARKETING DRUG SURVEILLANCE SCHEME ON SMALL COMPUTERS
    MOUSSA, MAA
    METHODS OF INFORMATION IN MEDICINE, 1982, 21 (04) : 181 - 186
  • [47] Utility of electronic health records to support post-marketing drug safety surveillance
    Lin, Nancy D.
    Calderbank, Jenna
    Anderson, David
    Seeger, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 415 - 415
  • [48] Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
    Wakabayashi, Tomohito
    Nakatsuji, Takahiro
    Kambara, Hiroko
    Niinomi, Iku
    Oyama, Saki
    Inada, Ayaka
    Ueno, Sayaka
    Uchida, Mayako
    Iwanaga, Kazunori
    Iida, Tatsuya
    Hosohata, Keiko
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2022, 17 (02) : 144 - 148
  • [49] Role of the Post-Marketing Authorisation Studies in Drug Risk Surveillance: Specifications and Methodologies
    Tubach, Florence
    Lamarque-Garnier, Veronique
    Castot, Anne
    THERAPIE, 2011, 66 (04): : 355 - 362
  • [50] A Temporal Interestingness Measure for Drug Interaction Signal Detection in Post-marketing Surveillance
    Ji, Yanqing
    Ying, Hao
    Tran, John
    Dews, Peter
    Mansour, Ayman
    Massanari, R. Michael
    2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2014, : 2722 - 2725
12345